| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.35M | $861.51K | $686.58K | $773.42K | $233.10K |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$2.35M | -$861.51K | -$686.58K | -$773.42K | -$233.10K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $1.60B | $284.56M | $137.59M | $2.42M | $13.66M |
| EPS (basic) | 16.9500 | 5.5300 | 2.7200 | 0.0400 | 0.4000 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |